Rising Up: Interim 24-week analysis

Published: 10 November 2021| Version 1 | DOI: 10.17632/h2krvxjtzv.1
Contributor:
Henrique Teixeira

Description

A phase 3 randomized, multi-center, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients in Japan with moderate-to-severe atopic dermatitis (Rising Up): Interim 24-week analysis

Files

Categories

Atopic Dermatitis

Licence